Significance of circulating tumor cells in metastatic triple-negative breast cancer patients within a randomized, phase II trial: TBCRC 019
- Translational Breast Cancer Research Consortium (TBCRC)
Research output: Contribution to journal › Article › peer-review
51
Link opens in a new tab
Scopus
citations